{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:39:03Z","timestamp":1787024343997,"version":"build-2736575974"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EB"],"DOI":"10.2147\/eb.s94449","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T11:38:52Z","timestamp":1464003532000},"page":"81","source":"Crossref","is-referenced-by-count":30,"title":["Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy"],"prefix":"10.2147","author":[{"given":"Haibo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,5]]},"container-title":["Eye and Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=30486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:47:32Z","timestamp":1477853252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/anti-vegf-therapy-in-the-management-of-retinopathy-of-prematurity-what-peer-reviewed-article-EB"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/eb.s94449","relation":{},"ISSN":["1179-2744"],"issn-type":[{"value":"1179-2744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}